Literature DB >> 24471393

Prostate imaging: evaluation of a reusable two-channel endorectal receiver coil for MR imaging at 1.5 T.

Masoom A Haider1, Axel Krieger, Christine Elliott, Michael R Da Rosa, Laurent Milot.   

Abstract

PURPOSE: To prospectively compare image quality with use of a two-channel solid reusable phased-array endorectal receiver coil (SPAC) with that of the single-channel inflatable endorectal balloon coil currently in widespread use for 1.5-T magnetic resonance (MR) imaging of the prostate.
MATERIALS AND METHODS: Institutional review board approval and informed consent were obtained. Multiparametric prostate MR imaging at 1.5 T was performed in patients who were suspected of having cancer. Thirty consecutive patients were included (mean age, 66.1 years; range, 49-76 years). The first 15 patients were imaged by using a balloon coil and an eight-channel external array, and the remaining 15 were imaged with a SPAC alone. One patient was imaged with both techniques. Axial T2-weighted images acquired at both standard and high spatial resolution were used to compare image quality between coils. Qualitative assessments of image quality were made separately by three radiologists. Signal-to-noise ratio (SNR) profiles were determined on a pixel-by-pixel basis in a 1-cm central band in the prostate by using T1-weighted axial images at the apex, midgland, and base. Interrater reliability was determined by using a two-way intraclass correlation coefficient, qualitative scores were compared by using the Student t test for independent samples, and SNR profiles were plotted by using a Biot-Savart curve approximation.
RESULTS: SNR of the SPAC was significantly better compared with that of the balloon coil at distances up to 3.0 cm at the apex and 3.5 cm at the base and midgland (P < .001). There was a 7% improvement in SNR at the mean maximal anteroposterior prostate dimension in this cohort and a 96% improvement at half this distance. At both standard and high spatial resolution, significant improvements in overall image quality (P = .015 and P < .001, respectively), visibility of the anterior gland (P = .009 and P < .001, respectively), and noise (P < .001 and P < .001, respectively) were seen when the SPAC was used. Interrater reliability was 0.536 (95% confidence interval: 0.461, 0.603).
CONCLUSION: Both SNR and image quality were significantly improved with use of the SPAC at 1.5 T compared with use of the single-channel inflatable endorectal balloon coil. © RSNA, 2013.

Entities:  

Mesh:

Year:  2013        PMID: 24471393     DOI: 10.1148/radiol.13130811

Source DB:  PubMed          Journal:  Radiology        ISSN: 0033-8419            Impact factor:   11.105


  4 in total

1.  Pulse sequence considerations for simulation and postimplant dosimetry of prostate brachytherapy.

Authors:  Jingfei Ma; Marinus A Moerland; Aradhana M Venkatesan; Tharakeswara K Bathala; Rajat J Kudchadker; Kristy K Brock; Steven J Frank
Journal:  Brachytherapy       Date:  2017-01-04       Impact factor: 2.362

Review 2.  Multiparametric MRI for localized prostate cancer: lesion detection and staging.

Authors:  Daniel J A Margolis
Journal:  Biomed Res Int       Date:  2014-11-30       Impact factor: 3.411

3.  Prostate MRI using a rigid two-channel phased-array endorectal coil: comparison with phased array coil acquisition at 3 T.

Authors:  Sara Lewis; Aasrith Ganti; Pamela Argiriadi; Ally Rosen; Stefanie Hectors; Sahar Semaan; Christopher Song; Steve Peti; Maxwell Segall; Kezia George; Vaneela Jaikaran; Sebastian Villa; David Kestenbaum; Nicholas Voutsinas; John Doucette; Ashutosh Tewari; Ardeshir R Rastinehad; Bachir Taouli
Journal:  Cancer Imaging       Date:  2022-03-16       Impact factor: 3.909

4.  Quality Comparison of 3 Tesla multiparametric MRI of the prostate using a flexible surface receiver coil versus conventional surface coil plus endorectal coil setup.

Authors:  T Ullrich; M D Kohli; M A Ohliger; K Magudia; S S Arora; T Barrett; L K Bittencourt; D J Margolis; L Schimmöller; B Turkbey; A C Westphalen
Journal:  Abdom Radiol (NY)       Date:  2020-07-21
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.